The FDA has issued a RECALL for Fresenius Medical Care North America’s dialysis products, NaturaLyte® Liquid Acid Concentrate and Naturalyte GranuFlo® (powder) Acid Concentrate. GranuFlo® is manufactured by Fresenius and is used to provide bicarbonates during dialysis to neutralize acid build-up that occurs during the waste-removal process. GranuFlo® is used in Fresenius dialysis clinics worldwide, as well as administered to an estimated 125,000 patients in clinics operated by other providers.
Many dialysis patients have suffered potentially dangerous heart problems after undergoing dialysis treatment with these products, including:
• Heart attack
• Sudden cardiac death
• Cardiopulmonary arrest
• Cardiovascular death
If you, a loved-one or a friend believe GranuFlo® and NaturaLyte® caused or contributed to the development of heart problems including a sudden heart attack or cardiac arrest, hemodialysis cardiac arrest or cardiopulmonary arrest, stroke, arrhythmia, or death, you may want to speak with a lawyer to determine if you have a right to compensation for your injuries. If you or someone you know has been affected by the GranuFlo and NaturaLyte recall, please feel free to call the Philadelphia products liability attorneys at Galfand Berger, LLP at 1-800-222-8792 or contact us online.